Abstract

Creating a cDNA library for deep mRNA sequencing (mRNAseq) is generally done by random priming, creating multiple sequencing fragments along each transcript. A 3′-end-focused library approach cannot detect differential splicing, but has potentially higher throughput at a lower cost, along with the ability to improve quantification by using transcript molecule counting with unique molecular identifiers (UMI) that correct PCR bias. Here, we compare an implementation of such a 3′-digital gene expression (3′-DGE) approach with “conventional” random primed mRNAseq. Given our particular datasets on cultured human cardiomyocyte cell lines, we find that, while conventional mRNAseq detects ~15% more genes and needs ~500,000 fewer reads per sample for equivalent statistical power, the resulting differentially expressed genes, biological conclusions, and gene signatures are highly concordant between two techniques. We also find good quantitative agreement at the level of individual genes between two techniques for both read counts and fold changes between given conditions. We conclude that, for high-throughput applications, the potential cost savings associated with 3′-DGE approach are likely a reasonable tradeoff for modest reduction in sensitivity and inability to observe alternative splicing, and should enable many larger scale studies focusing on not only differential expression analysis, but also quantitative transcriptome profiling.

Details

Title
A Comparison of mRNA Sequencing with Random Primed and 3′-Directed Libraries
Author
Xiong, Yuguang 1   VIAFID ORCID Logo  ; Soumillon, Magali 2 ; Wu, Jie 3 ; Hansen, Jens 1 ; Hu, Bin 1 ; Johan G C van Hasselt 1   VIAFID ORCID Logo  ; Jayaraman, Gomathi 1 ; Lim, Ryan 3 ; Bouhaddou, Mehdi 1 ; Ornelas, Loren 4 ; Bochicchio, Jim 5 ; Lenaeus, Lindsay 4 ; Stocksdale, Jennifer 6 ; Shim, Jaehee 1 ; Gomez, Emilda 4 ; Sareen, Dhruv 7   VIAFID ORCID Logo  ; Svendsen, Clive 7 ; Thompson, Leslie M 8 ; Mahajan, Milind 9 ; Iyengar, Ravi 1 ; Sobie, Eric A 1 ; Azeloglu, Evren U 1   VIAFID ORCID Logo  ; Birtwistle, Marc R 10 

 Department of Pharmacological Sciences and DToxS LINCS Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA 
 Broad Institute of MIT and Harvard, Cambridge, MA, USA; Berkeley Lights, Inc. 5858 Horton St., Emeryville, CA, USA 
 Department of Biological Chemistry, University of California, Irvine, CA, USA; UCI MIND, University of California, Irvine, CA, USA 
 Board of Governors-Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; iPSC Core, The David and Janet Polak Foundation Stem Cell Core Laboratory, Los Angeles, CA, USA 
 Broad Institute of MIT and Harvard, Cambridge, MA, USA 
 UCI MIND, University of California, Irvine, CA, USA 
 Board of Governors-Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; iPSC Core, The David and Janet Polak Foundation Stem Cell Core Laboratory, Los Angeles, CA, USA; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA 
 Department of Biological Chemistry, University of California, Irvine, CA, USA; UCI MIND, University of California, Irvine, CA, USA; Department of Psychiatry and Human Behavior, Neurobiology and Behavior, University of California, Irvine, CA, USA 
 Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA 
10  Department of Pharmacological Sciences and DToxS LINCS Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Chemical and Biomolecular Engineering, Clemson University, Clemson, SC, USA 
First page
1
Publication year
2017
Publication date
Nov 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1961816218
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.